Brief: Exscientia Files For U.S. IPO

Bristol-Myers Squibb

10/09/2021 16:56

Sept 10 (Reuters) - 
    * EXSCIENTIA FILES FOR U.S. IPO OF UP TO $100 MILLION – SEC FILING
    * EXSCIENTIA - HAVE APPLIED TO LIST ADSS ON NASDAQ GLOBAL MARKET UNDER SYMBOL “EXAI”.
    * EXSCIENTIA - THIS IS AN INITIAL OFFERING OF AMERICAN DEPOSITARY SHARES, OR ADSS,
REPRESENTING
ORDINARY SHARES OF EXSCIENTIA PLC
    * EXSCIENTIA SAYS GOLDMAN SACHS & CO. LLC, MORGAN STANLEY, BOFA SECURITIES, BARCLAYS ARE
AMONG
UNDERWRITERS TO IPO
    * EXSCIENTIA - BILL & MELINDA GATES FOUNDATION HAS AGREED TO PURCHASE FROM CO, CONCURRENTLY
WITH
THE OFFERING IN PRIVATE PLACEMENT, $35.0 MILLION OF ADSS
    * EXSCIENTIA - PRIOR TO COMPLETION OF THE OFFERING, INTEND TO RE-REGISTER REGISTRANT AS A
PUBLIC
LIMITED COMPANY UNDER THE LAWS OF ENGLAND AND WALES
    * EXSCIENTIA - PRIOR TO COMPLETION OF THIS OFFERING,  WILL CHANGE REGISTRANT’S NAME FROM
EXSCIENTIA LIMITED TO EXSCIENTIA PLC
    * EXSCIENTIA - LISTS EVOTEC SE, SOFTBANK GROUP CORP, NOVO HOLDINGS A/S UNDER 5% OR GREATER
SHAREHOLDERS
    * EXSCIENTIA - LISTS ENTITIES AFFILIATED WITH BLACKROCK, INC, CELGENE CORP, GT HEALTHCARE
PARTNERS
FUND III, L.P UNDER 5% OR GREATER SHAREHOLDERS
    * EXSCIENTIA - PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR PURPOSE OF CALCULATING SEC
REGISTRATION FEE

Source text - https://bit.ly/2XcDlbq

 ((Reuters.Briefs@thomsonreuters.com;))